Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Camp Lejeune Cases
  • Drug Injury
  • Free Case Evaluation
  • About Us

There Will Be No Belviq Generic Drugs After Belviq Drug Recall in 2020

April 13, 2021 By Law Offices of Thomas J. Lamb, P.A.

There has been some further FDA action regarding Belviq which is related to the 2020 Belviq drug recall that was due to an increased risk of cancer. This further FDA action means there will be no Belviq generic drugs after the Belviq drug recall in 2020. This February 26, 2021 Notice item, “Determination That BELVIQ (Lorcaserin Hydrochloride) … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Belviq, Colon cancer, Colorectal Cancer, lung cancer, Pancreatic Cancer, Rectal cancer

FDA Belviq Recall Decision Came After Safety Data Review Found Excess Cancers Risks

September 22, 2020 By Law Offices of Thomas J. Lamb, P.A.

In this FDA staff article, “Cancer risk associated with lorcaserin — The FDA’s review of the CAMELLIA-TIMI 61 trial”, which was published by the New England Journal of Medicine (NEJM), the early 2020 FDA Belviq recall decision was explained. Essentially, this FDA action after a careful analysis of Belviq safety data that revealed excess … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Belviq, Colon cancer, leukemia, lung cancer, Pancreatic Cancer, Rectal cancer

Zantac Recall: Chemical NDMA In Zantac Pills Can Cause Cancers

June 4, 2020 By Law Offices of Thomas J. Lamb, P.A.

The contaminant chemical NDMA in Zantac pills is a substance that could cause cancer of the: pancreas (pancreatic cancer), stomach, colon, rectum (rectal cancer), bladder, or kidney (renal cancer). On April 1, 2020, the FDA announced that it was requesting a Zantac recall due to the presence of NDMA in Zantac and all other medications containing … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Bladder Cancer, Colon cancer, Kidney cancer, Pancreatic Cancer, Rectal cancer, Stomach cancer, Zantac

After Drug Recall Belviq Lawsuits Alleging Failure To Warn About Cancer

May 21, 2020 By Law Offices of Thomas J. Lamb, P.A.

Following the Belviq recall in February 2020 some of those patients on Belviq developing cancer filed Belviq lawsuits alleging a failure to warn about the risk of cancer associated with Belviq. We are investigating possible Belviq lawsuits that involve patients on Belviq developing cancer. At the present time, our focus for these Belviq lawsuits … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Belviq, Colon cancer, lung cancer, Pancreatic Cancer, Rectal cancer

Belviq Recall Due To Certain Cancers: Pancreatic, Colon, Rectal, And Lung

February 18, 2020 By Law Offices of Thomas J. Lamb, P.A.

The diet drug Belviq is being withdrawn from the US market because a Belviq safety clinical trial shows an increased occurrence of cancer cases. This February 2020 Belviq FDA Drug Safety Communication announced the Belviq recall, “FDA requests the withdrawal of the weight-loss drug Belviq, Belviq XR (lorcaserin) from the market”, and noted that … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Belviq, Colon cancer, lung cancer, Pancreatic Cancer, Rectal cancer

Zantac Cancer Lawsuits Filed After FDA Warnings About NDMA In Ranitidine

December 4, 2019 By Law Offices of Thomas J. Lamb, P.A.

Zantac cancer lawsuits are for being filed for patients diagnosed with certain types of cancer after using Zantac (ranitidine) for heartburn associated with acid indigestion and sour stomach. According to medical research, some of the cancers associated with Zantac use due to NDMA exposure include: Stomach cancerColon cancerRectal … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Bladder Cancer, Colon cancer, Kidney cancer, Pancreatic Cancer, Rectal cancer, Stomach cancer, Zantac

Pancreatic Cancer: Side Effect Of Onglyza, Nesina, Tradjenta, Other DPP-4 Inhibitor Diabetes Drugs?

September 26, 2019 By Law Offices of Thomas J. Lamb, P.A.

There is new medical research concerning pancreatic cancer linked to diabetes medicines in the DPP-4 inhibitor drug class. In more detail, the use of dipeptidyl peptidase-4 inhibitors (DPP-4i) diabetes medicines may be associated with an increased risk for pancreatic cancer in patients with newly diagnosed type 2 diabetes. This finding comes … [Read more...]

Filed Under: Unsafe Drugs Tagged With: diabetes drugs, diabetes drugs side effects, drug side effects, Nesina, Onglyza, Pancreatic Cancer, Tradjenta

Current Number Of Lawsuits Filed In The Four Diabetes Drugs Federal Court MDL Cases

February 23, 2018 By Law Offices of Thomas J. Lamb, P.A.

From the February 15, 2018 version of this document, “MDL Statistics Report – Distribution of Pending MDL Dockets by Actions Pending” (accessed 2/21/18), published by the United States Judicial Panel on Multidistrict Litigation (JPML), we get the current number of cases filed in each of the four federal court Multidistrict Litigation (MDL) cases … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Byetta, Diabetic Ketoacidosis (DKA), Farxiga, Foot Amputation, Heart Failure, Invokamet, Invokana, Janumet, Januvia, Kombiglyze, Leg Amputation, Onglyza, Pancreatic Cancer, Toes Amputation, Victoza

Saxenda May Increase Risks Of Pancreatic Cancer / Pancreas Malignancy

February 2, 2018 By Law Offices of Thomas J. Lamb, P.A.

While the current Prescribing Information, or drug label, for Saxenda (accessed 1/30/18) has a so-called “Black-Box Warning” for the risk of thyroid C-cell tumors, a type of thyroid cancer, and pancreatitis is mentioned in the Warnings and Precautions section, there is nothing about an increased risk of pancreatic cancer. In 2014, the FDA … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Pancreatic Cancer, Saxenda, Victoza

Pancreatic Cancer Lawsuits Reinstated for Incretin-Based Diabetes Drugs

January 2, 2018 By Law Offices of Thomas J. Lamb, P.A.

Background Among the several different types of therapies indicated for treating type 2 diabetes are increatin mimetics.  The medications approved by the FDA that fall into this class of drugs are: Byetta (exenatide) Bydureon (exenatide) Januvia (sitagliptin) Janumet (sitagliptin) Victoza (liraglutide) Previous scientific … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Bydureon, Byetta, drug injury lawsuits, increatin mimetics, incretin-based diabetes drugs, Janumet, Januvia, new trials incretin therapy diabetes drugs, Pancreatic Cancer, side effects, Victoza

  • 1
  • 2
  • Next Page »

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • Camp Lejeune Cases
  • GenX Water Cancer Cases
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Philips Breathing Devices Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2023 · Law Offices of Thomas J. Lamb, P.A.